How big is NGM Biopharmaceuticals, Inc.?

Jun 22 2025 06:15 PM IST
share
Share Via
As of Apr 04, NGM Biopharmaceuticals, Inc. has a market capitalization of 128.53 million and reported net sales of 4.42 million with a net profit of -142.38 million over the latest four quarters. Shareholder's funds are 148.64 million, and total assets amount to 168.87 million as of Dec'23.
As of Apr 04, NGM Biopharmaceuticals, Inc. has a market capitalization of 128.53 million, categorizing it as a Micro Cap company.

As of Apr 04, the sum of net sales for the latest four quarters is 4.42 million, while the sum of net profit for the same period is -142.38 million.

As of Dec'23, the shareholder's funds are reported at 148.64 million, and total assets amount to 168.87 million.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
What does NGM Biopharmaceuticals, Inc. do?
Jun 22 2025 07:02 PM IST
share
Share Via